Published in BMC Gastroenterol on November 28, 2011
Anticoagulation policy after venous resection with a pancreatectomy: a systematic review. HPB (Oxford) (2013) 0.84
Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients. HPB (Oxford) (2015) 0.84
Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol (2012) 0.79
Concurrent hepatic artery and portal vein thrombosis after orthotopic liver transplantation with preserved allografts. Case Rep Transplant (2014) 0.75
Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis. Transpl Int (2016) 0.75
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology (2000) 3.16
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol (2010) 2.41
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol (2009) 2.14
Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor. J Thromb Haemost (2005) 1.73
Vascular complications after liver transplantation: a 5-year experience. AJR Am J Roentgenol (1986) 1.73
An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology (2009) 1.54
High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy. Transpl Int (2008) 1.52
Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant (2009) 1.34
Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels. J Hepatol (1999) 1.25
Hepatic artery thrombosis following orthotopic liver transplantation: a 10-year experience from a single centre in the United Kingdom. Liver Transpl (2006) 1.24
Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem (2003) 1.24
Hepatic artery stenosis and thrombosis in transplant recipients: Doppler diagnosis with resistive index and systolic acceleration time. Radiology (1994) 1.21
Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology (2005) 1.17
Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes. Liver Transpl (2001) 1.15
Outcomes after liver transplantation in young infants. J Pediatr Gastroenterol Nutr (2008) 1.01
Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. Blood (1998) 0.95
A hypercoagulable state follows orthotopic liver transplantation. Hepatology (1990) 0.94
The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis. J Clin Gastroenterol (2000) 0.93
Does intraoperative hepatic artery flow predict arterial complications after liver transplantation? Transplantation (1998) 0.87
Evaluation of the coagulation and inflammatory responses in solid organ transplant recipients and donors. Clin Transplant (2009) 0.87
Urgent revascularization of liver allografts after early hepatic artery thrombosis. Transplantation (1996) 0.86
Von Willebrand gene expression in damaged human liver. Hepatogastroenterology (2004) 0.81
Factor V Leiden and hepatic artery thrombosis after liver transplantation. Clin Transplant (2006) 0.80
Hepatic artery thrombosis after liver transplantation: more than just a surgical complication? Transpl Int (2008) 0.79
Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation. Transplantation (2005) 0.78
Factor V Leiden in absence of activated protein C resistance after orthotopic liver transplantation in a patient without thrombosis but with familial thrombophilia. Haematologica (2000) 0.78
Phenotypic correction of activated protein C resistance following orthotopic liver transplantation. Blood Coagul Fibrinolysis (1996) 0.78
Living donor liver transplantation: usefulness of hemostatic and prothrombotic screening in potential donors. Transplant Proc (2009) 0.77
Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg (1998) 0.77
Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03). Leuk Lymphoma (2011) 2.04
Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. Ann Hematol (2010) 1.57
Effects of body position on resting lung volume in overweight and mildly to moderately obese subjects. Respir Care (2009) 1.42
Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantation. Liver Transpl (2011) 1.40
Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma. Leuk Res (2010) 1.40
Clinical and radiologic features of pigmented villonodular synovitis of the foot: report of eight cases. J Am Podiatr Med Assoc (2007) 1.38
Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility. Liver Transpl (2008) 1.19
Atrophic humeral shaft nonunion treated with teriparatide (rh PTH 1-34): a case report. J Shoulder Elbow Surg (2010) 1.19
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial. Blood (2012) 1.19
Successful treatment of mucor infection after liver or pancreas-kidney transplantation. Transplantation (2002) 1.04
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance. Blood (2011) 1.03
Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis. J Mol Diagn (2009) 1.02
Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection. Ther Drug Monit (2009) 0.98
Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation. Liver Transpl (2006) 0.98
HIV infection and renal transplantation. Nephrol Dial Transplant (2010) 0.97
Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host. J Virol (2003) 0.97
GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators? Blood (2014) 0.96
Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response. Br J Haematol (2008) 0.95
p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope (2003) 0.94
Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia. Am J Hematol (2009) 0.91
NMR methods for unravelling the spectra of complex mixtures. Nat Prod Rep (2010) 0.91
Pulmonary arterial dysfunction in insulin resistant obese Zucker rats. Respir Res (2011) 0.90
Long-term follow-up of donor chimerism and tolerance after human liver transplantation. Liver Transpl (2009) 0.90
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts. Ann Hematol (2014) 0.89
Backyard chicken flocks pose a disease risk for neotropic birds in Costa Rica. Avian Dis (2008) 0.89
Early maternal deprivation and neonatal single administration with a cannabinoid agonist induce long-term sex-dependent psychoimmunoendocrine effects in adolescent rats. Psychoneuroendocrinology (2007) 0.88
Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission. Clin Cancer Res (2013) 0.87
Melatonin treatment protects liver of Zucker rats after ischemia/reperfusion by diminishing oxidative stress and apoptosis. Eur J Pharmacol (2012) 0.87
Different patterns of pulmonary vascular disease induced by type 1 diabetes and moderate hypoxia in rats. Exp Physiol (2012) 0.86
Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats. Eur J Pharmacol (2006) 0.86
The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis. Haematologica (2014) 0.85
Incidence and risk factors for the development of lung tumors after liver transplantation. Transpl Int (2007) 0.85
Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig Dis Sci (2003) 0.84
Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005<65y trials. Am J Pathol (2012) 0.84
Seroprevalence of viral infections in domestic cats in Costa Rica. J Vet Med Sci (2009) 0.84
Advanced donor age increases the risk of severe recurrent hepatitis C after liver transplantation. Transpl Int (2005) 0.83
Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg (2005) 0.83
Conversion from cyclosporin A to tacrolimus as a non-surgical alternative to reduce gingival enlargement: a preliminary case series. J Periodontol (2003) 0.83
Rotavirus genotypes in Costa Rica, Nicaragua, Honduras and the Dominican Republic. Intervirology (2010) 0.83
Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C. Liver Transpl (2009) 0.83
Triterpene glycosides from the Far Eastern sea cucumber Cucumaria conicospermium. J Nat Prod (2003) 0.83
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. Int J Cancer (2014) 0.82
Anesthesia technique for endobronchial ultrasound-guided fine needle aspiration of mediastinal lymph node. J Cardiothorac Vasc Anesth (2007) 0.81
Switching to sirolimus monotherapy for de novo tumors after liver transplantation. A preliminary experience. Hepatogastroenterology (2011) 0.81
Myeloablative treatments for multiple myeloma: update of a comparative study of different regimens used in patients from the Spanish registry for transplantation in multiple myeloma. Leuk Lymphoma (2002) 0.81
Maturation of O2 sensing and signaling in the chicken ductus arteriosus. Am J Physiol Lung Cell Mol Physiol (2009) 0.81
Sequence polymorphisms in the long terminal repeat of bovine leukemia virus: evidence for selection pressures in regulatory sequences. Virus Res (2006) 0.80
The kappa-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety. Behav Brain Res (2005) 0.80
Cardiovascular risk factors in 116 patients 5 years or more after liver transplantation. Transpl Int (2002) 0.80
Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol (2012) 0.79
High incidence of delayed graft function in HIV-infected kidney transplant recipients. Transpl Int (2013) 0.78
Paroxysmal nocturnal hemoglobinuria: a single Spanish center's experience over the last 40 yr. Eur J Haematol (2014) 0.78
Decreasing hormonal promotion is key to breast cancer prevention. Endocrine (2009) 0.78
Simplifying the detection of MUTYH mutations by high resolution melting analysis. BMC Cancer (2010) 0.78
Survey of the black howler monkey, alouatta pigra, population at the Mayan site of Palenque, Chiapas, Mexico. Primates (2002) 0.78
Rotavirus genotypes in Costa Rica, Nicaragua, Honduras and the Dominican Republic. Intervirology (2010) 0.77
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era. Cancer Epidemiol Biomarkers Prev (2014) 0.77
Efficacy and safety of reduced-intensity induction therapy with a bortezomib-based regimen in elderly patients with multiple myeloma. Ther Adv Hematol (2012) 0.77
Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia. Hepat Res Treat (2011) 0.77
Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma. Br J Haematol (2013) 0.76
HLA genes in Amerindian immigrants to Madrid (Spain): epidemiology and a virtual transplantation waiting list: Amerindians in Madrid (Spain). Mol Biol Rep (2010) 0.76
Rapid progression from oral leukoplakia to carcinoma in an immunosuppressed liver transplant recipient. Oral Oncol (2003) 0.76
Anemia control in renal transplant recipients receiving continuous erythropoietin receptor activator (C.E.R.A.) treatment: the AnemiaTrans Study. Adv Ther (2012) 0.76
Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients. Transplantation (2011) 0.76
Ceramide mediates acute oxygen sensing in vascular tissues. Antioxid Redox Signal (2013) 0.76
Bicarbonate gradients modulate growth and colony morphology in Aspergillus nidulans. FEMS Microbiol Lett (2009) 0.76
JAK2 exon 12 mutations were not found in liver transplant recipients with or without pretransplant portal vein thrombosis. Eur J Gastroenterol Hepatol (2014) 0.75
Antiphospholipid syndrome in a patient suffering from congenital dyserythropoietic anemia type III. Ann Hematol (2015) 0.75
The real value of lower esophageal sphincter measurement for predicting acid gastroesophageal reflux or Barrett's esophagus. J Gastrointest Surg (2005) 0.75
[Efficacy preemptive therapy with ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients]. Med Clin (Barc) (2004) 0.75
Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3. Br J Haematol (2012) 0.75
Description of M-shaped preperitoneal hernioplasty for inguinocrural hernias. Am J Surg (2003) 0.75
SEROPREVALENCE AND MOLECULAR CHARACTERIZATION OF FERLAVIRUS IN CAPTIVE VIPERS OF COSTA RICA. J Zoo Wildl Med (2017) 0.75
An event-related potentials study of identity positive and negative priming. Int J Psychophysiol (2007) 0.75
Quantitative ultrasound of the calcaneus in long-term liver or cardiac transplantation patients. J Clin Densitom (2006) 0.75
Do shade-grown coffee plantations pose a disease risk for wild birds? Ecohealth (2013) 0.75
[Massive hepatic abscess in a liver transplant patient secondary to a late arterial graft thrombosis]. Cir Esp (2013) 0.75
Type 2 diabetes screening test by means of a pulse oximeter. IEEE Trans Biomed Eng (2016) 0.75
Blockade of endothelial G(i) protein enhances early engraftment in intraportal cell transplant to mouse liver. Cell Transplant (2012) 0.75